Technical Analysis for RHHBY - Roche Hldg Ltd Spons

Grade Last Price % Change Price Change
grade B 34.41 -0.43% -0.1500
RHHBY closed down 0.43 percent on Friday, August 23, 2019, on 40 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Flat Down
See historical RHHBY trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Stochastic Sell Signal Bearish -0.43%
50 DMA Support Bullish -0.43%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.43%
Narrow Range Bar Range Contraction -0.43%
Doji - Bullish? Reversal -0.43%
Overbought Stochastic Strength -0.43%
Gapped Down Weakness -0.43%

Older signals for RHHBY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Life Sciences Pharmaceutical Industry In China Pharmaceutical Products Infectious Diseases Disease Neuroscience Gene Expression Diabetes Care Genentech Hoffmann La Roche Chugai Pharmaceutical Co. Roche
Is RHHBY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 35.9
52 Week Low 25.1
Average Volume 1,047,837
200-Day Moving Average 33.2247
50-Day Moving Average 34.4852
20-Day Moving Average 34.3473
10-Day Moving Average 34.726
Average True Range 0.811
ADX 42.19
+DI 16.0082
-DI 58.4603
Chandelier Exit (Long, 3 ATRs ) 32.897
Chandelier Exit (Short, 3 ATRs ) 27.533
Upper Bollinger Band 35.3739
Lower Bollinger Band 33.3207
Percent B (%b) 0.53
BandWidth 5.977762
MACD Line 0.1438
MACD Signal Line 0.132
MACD Histogram 0.0119
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.2500
Resistance 3 (R3) 35.3367 35.1433 35.1100
Resistance 2 (R2) 35.1433 34.9294 35.1000 35.0633
Resistance 1 (R1) 34.7767 34.7973 34.6800 34.6900 35.0166
Pivot Point 34.5833 34.5833 34.5350 34.5400 34.5833
Support 1 (S1) 34.2167 34.3694 34.1200 34.1300 33.8034
Support 2 (S2) 34.0233 34.2373 33.9800 33.7567
Support 3 (S3) 33.6567 34.0233 33.7100
Support 4 (S4) 33.5700